Statements and Comment Letters

March 29, 2023 – PAVC and other stakeholders send letter of support to sponsors of the Telehealth Benefit Expansion for Workers Act (H.R. 824)  |  Read the Full Letter

March 29, 2023 – PAVC submits comments on two Drug Enforcement Agency (DEA) proposed rules related to the prescription of controlled substances, including buprenorphine, without a requirement for an in-person visit  |  Read the Full Letter

January 30, 2023 – PAVC submits comments on the bipartisan CONNECT for Health Act  |  Read the Full Letter

January 26, 2023 – PAVC signs stakeholder letter to CMS on extending telehealth codes through CY 2024  |  Read the Full Letter

November 15, 2022 – PAVC joined more than 350 other stakeholders in sending a letter to congressional leaders, urging Congress to extend the safe harbor allowing first-dollar coverage for certain telehealth services for those with HSA-eligible HDHPs before the end of the year  |  Read the Full Letter

September 13, 2022 – PAVC and 374 other organizations send letter to Senate leaders, urging legislative action this fall to ensure certainty for telehealth services  |  Read the Full Letter

August 30, 2022 – PAVC submits comments to CMS focused on telehealth policies, in response to the proposed CY 2023 Medicare Physician Fee Schedule (PFS) rule  |  Read the Full Comment

June 29, 2022 – PAVC and other telehealth stakeholders endorse the Telehealth Benefit Expansion for Workers Act  |  Read the Full Letter

March 3, 2022 – PAVC signed onto a stakeholder letter to DEA last week, urging them to collaborate with HHS to consider public health and health care access during the development of the Special Registration process for the use of telemedicine to prescribe controlled substances under the Ryan Haight Act  |  Read the Full Letter

February 8, 2022 – PAVC statement on introduction of Telehealth Extension and Evaluation Act  |  Read the Full Statement

January 14, 2022 – A letter was sent to leaders of the House Ways and Means Committee and the Senate Finance Committee, urging Congress to reinstate a telehealth provision that expired at the end of 2021, that allowed millions of Americans with high-deductible health plans (HDHPs) coupled with Health Savings Accounts (HSAs) to receive important telehealth services pre-deductible.  |  Read the Full Letter

November 10, 2021 – PAVC submits comments to the Senate Finance Committee, in response to their request for stakeholder feedback on mental health  |  Read the Full Comment

September 13, 2021 – PAVC submits comments to CMS focused on telehealth policies, in response to the proposed CY 2022 Medicare Physician Fee Schedule (PFS) rule  |  Read the Full Comment

May 21, 2021 – PAVC letter of support to Senators Daines and Cortez Masto supporting the re-introduction of the Telehealth Expansion Act of 2021 (S. 1704)  |  Read the Full Letter

March 17, 2021 – PAVC letter of support to Representatives Carter and Blunt-Rochester supporting the introduction of the Telehealth Modernization Act (H.R. 1332)  |  Read the Full Letter

December 23, 2020 – PAVC comments in response to the Department of Health and Human Services request for information on regulatory relief to support economic recovery  |  Read the Full Comment

October 5, 2020 – PAVC comments in response to the Medicare CY 2021 Physician Fee Schedule Proposed Rule [CMS-1734-P]  |  Read the Full Comment

August 14, 2020 – PAVC comments in response to the proposed Republican House Ways and Means Committee telehealth legislation  |  Read the Full Comment

Issue Briefs and Advocacy Materials

DEA proposes limited post-PHE telemedicine prescription of controlled substances  |  View the Special Report

Snapshot of expanded access to virtual care during the pandemic  |  View the Infographic

Repealing the in-person requirement for mental telehealth services  |  Read the Full Brief

Congress must act to ensure continued access to telehealth services for those with HSA-eligible HDHPs
Read background document  |  View the Infographic